Automated Tumour-Stroma Interface Zone Detection for Anti-Tumour Response Assessment by Immunogradient Indicators

Summary of the technology

The Immunogradient indicators are aimed at assessing tissue immune response properties in the context of tumour microenvironment and has a potential for prognostic/predictive biomarkers in cancer patients.

Vilnius University

Details of the Technology Offer

The novel set of Immunogradient indicators are based on an automated grid analytics in digital immunohistochemistry images. The method first identifies the tumour edge, shown as yellow hexagons below, using a set of explicit rules applied to image analysis data of tissue classes and their areas. Then, by ranking the hexagons by the distance to the tumour edge the tumour-stroma interface zone (IZ) of any width can be extracted. Below, green hexagons represent the stroma aspect and red hexagons the tumour aspect of the IZ. The interface zone allows computing tumour-infiltrating lymphocyte density profiles across the tumour-stroma interface zone (IZ), see insert below. From the density profile, the Immunogradient indicators, which express lymphocyte “propagation toward-tumour gradient” can be calculated, and these were found to strongly predict overall survival of both hormone receptor positive breast cancer and colorectal cancer patients.

FIELDS OF APPLICATION

• medicine,

• biomedicine,

• immunology,

• pharmacy,

•clinical diagnostics (oncology).

TECHNOLOGY READINESS LEVEL

Proof of concept that data-driven, automated, operator-independent IZ sampling enables spatial immune response measurement in the tumor-host interaction frontline for prediction of disease outcomes.

INTELLECTUAL PROPERTY

PCT patent application (pending); Lithuanian patent application (LT2019 509). Applicants: Vilnius University (Lithuania).

INVENTORS 

Group of researchers from Vilnius University Faculty of Medicine: Allan Rasmusson, Dovilė Žilėnaitė, Aušrinė Nestarenkaitė, Renaldas Augulis, Arvydas Laurinavičius.

PUBLICATIONS

Rasmusson, A., Zilenaite, D., Nestarenkaite, A., Augulis, R., Laurinaviciene, A., Ostapenko, V., Poskus, T., Laurinavicius, A. “Immunogradient Indicators for Antitumor Response Assessment by Automated Tumor-Stroma Interface Zone Detection”, The American Journal of Pathology, (2020); https://doi.org/10.1016/j.ajpath.2020.01.018.   

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Cytology, Cancerology, Oncology
  • E-Health
  • Medical Health related
  • Clinical Medicine
  • Oncology
  • Diagnostic
  • Medical imaging
  • Ultrasound imaging

About Vilnius University

Vilnius University is the largest Lithuanian higher education and research institution. We are open for collaborative research, contract research or any cooperation activities with partners from business and public organizations. Multidisciplinary approach on R&D activities at Vilnius University provides unique opportunity to incorporate methodologies, perspectives, data and concepts from all scientific fields – biomedical, physical sciences, technologies, social sciences and humanities. We believe that the right mix of shared intentions with our partners and clients, outstanding teams of university researchers and open access to modern R&D infrastructure deliver remarkable solutions that can change organizations, markets and society in general.

Vilnius University

Never miss an update from Vilnius University

Create your free account to connect with Vilnius University and thousands of other innovative organizations and professionals worldwide

Vilnius University

Send a request for information
to Vilnius University

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support